Results 11 to 20 of about 11,668 (183)

Estudio postautorización de la eslicarbazepina en el tratamiento de epilepsias farmacorresistentes: resultados preliminares

open access: yesNeurología, 2014
Resumen: Introducción: La eslicarbazepina (ESL) es un nuevo fármaco antiepiléptico (FAE) análogo de la carbamazepina (CBZ) y la oxcarbazepina (OXC). Analizamos su respuesta terapéutica inicial y el paso desde CBZ y OXC.
A. Massot   +4 more
doaj   +1 more source

¿Qué aportan los nuevos fármacos antiepilépticos?

open access: yesRevista Médica Clínica Las Condes, 2013
Casi 40% de los pacientes con epilepsia no responde a nuestra primera elección de fármacos antiepilépticos, (FAEs). Esto debería ser justificación suficiente para la búsqueda de nuevos compuestos.
Dr. Parra Jaime
doaj   +1 more source

Crisis de pánico, un reto diagnóstico

open access: yesActa Neurológica Colombiana, 2023
Las manifestaciones de pánico asociadas a la epilepsia del lóbulo temporal pueden ser difíciles de diferenciar de los ataques de pánico que hacen parte de los trastornos de ansiedad.
Martin Torres Z   +3 more
doaj   +2 more sources

Ictal semiology in precuneus seizures: A systematic review

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective To evaluate the ictal semiology in seizures originating in the precuneus and to help guide seizure interpretation within the framework of presurgical evaluation. Methods This systematic review followed a Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) and a Quality Assessment tool for Diagnostic Accuracy ...
Erika Ignatius   +8 more
wiley   +1 more source

Uso de la electroencefalografía urgente por el neurólogo de guardia: utilidad en el diagnóstico del estatus epiléptico no convulsivo

open access: yesNeurología, 2018
Resumen: Introducción: Estudio que describe la experiencia en el uso del electroencefalograma urgente (EEGurg) por la guardia de neurología ante la sospecha de estatus epiléptico no convulsivo (EENC) y en otras indicaciones en un hospital terciario ...
J.U. Máñez Miró   +3 more
doaj   +1 more source

Emergency electroencephalogram: Usefulness in the diagnosis of nonconvulsive status epilepticus by the on-call neurologist

open access: yesNeurología (English Edition), 2018
Introduction: We aim to describe the use of emergency electroencephalogram (EmEEG) by the on-call neurologist when nonconvulsive status epilepticus (NCSE) is suspected, and in other indications, in a tertiary hospital. Subjects and methods: Observational
J.U. Máñez Miró   +3 more
doaj   +1 more source

Freedon study: Real‐life outcomes of cenobamate in different lines of treatment

open access: yesEpilepsia, EarlyView.
Abstract Objectives Cenobamate is an antiseizure medication (ASM) with proven effectiveness in individuals with highly refractory epilepsy. This study investigated the effectiveness and tolerability of cenobamate in different treatment lines and a less refractory setting. Methods This was a multicenter, retrospective, observational study.
Vicente Villanueva   +50 more
wiley   +1 more source

Estereoelectroencefalografía y ablación focal por radiofrecuencia para epilepsia farmacoresistente: primer caso en México

open access: yesAnales Médicos, 2023
La SEEG fue desarrollada en Francia a partir de 1949. Con las nuevas tecnologías de imagen y STX se ha perfeccionado vertiginosamente. Este método permite registrar fuera del quirófano, la actividad eléctrica por medio de electrodos intracerebrales ...
Enrique de Font-Réaulx   +7 more
doaj   +1 more source

Communication regarding sudden unexpected death in epilepsy to people with epilepsy and their caregivers: A scoping review from the ILAE Sudden Unexpected Death in Epilepsy Task Force

open access: yesEpilepsia, EarlyView.
Abstract Discussing sudden unexpected death in epilepsy (SUDEP) is difficult and sensitive for health care providers (HCPs), people with epilepsy (PwE), and caregivers. This scoping review examines the literature on SUDEP communication, focusing on need, timing, content, methods, facilitators, barriers, and outcomes. We performed a thematic analysis to
Amir Aschner   +5 more
wiley   +1 more source

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs

open access: yesEpilepsia, EarlyView.
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy